The Ledger
A federal whistleblower lawsuit accuses Alignment Healthcare of manufacturing the Medicare Advantage insurer’s first-ever profitable year, and the stock had its worst day in more than two years on the news. Hakan Kardes, Alignment’s former chief technology and transformation officer, filed a complaint July 9, 2026 in the U.S. District Court for the Central District of California alleging the company misclassified 8 million to 10 million dollars of routine software maintenance and bug-fix work as capital expenditures in 2024, rather than booking it as an operating expense, with another 10 million dollars misclassified in 2025. Correcting the 2024 number would turn Alignment’s reported 1.3 million dollars in positive adjusted EBITDA, its first full year in the black on that measure, into a loss of 7 million to 9 million dollars, and Kardes alleges CEO John Kao and other executives collected bonuses tied to hitting the inflated targets after he raised the issue internally in March 2025. Alignment shares fell 17 percent on July 8, 2026, their worst single day since February 2024; the company says the allegations are meritless and that an outside audit performed after Kardes came forward confirmed its accounting is reliable. Confidence: Medium. The allegations are unproven and contested, but the federal filing, the bonus mechanics, and the stock reaction are independently confirmed. Sources: Healthcare Dive’s report on the Kardes whistleblower lawsuit, Fierce Healthcare’s report on the Alignment whistleblower allegations, Yahoo Finance’s report on Alignment’s stock drop.
Astrana Health told the SEC its physician-enablement business generated 120.4 million dollars in gross Medicare ACO shared savings for 2024, with all eight of its accountable care organizations landing in the black, a clean sweep as the federal ACO REACH model heads into its final year. The Form 8-K, filed July 13, 2026, says five of Astrana’s ACOs participate in the Medicare Shared Savings Program and three in ACO REACH, and every one generated net as well as gross shared savings for the 2024 performance year. CEO Brandon Sim called the result “a powerful validation” of the company’s physician-centric model. Confidence: High on the filed figures; Medium on how representative the result is of Astrana’s overall financial picture, since the filing does not break out what share of company revenue these ACOs represent. Source: Astrana Health’s Form 8-K exhibit, SEC.
Minnesota’s attorney general held a public hearing today on Sutter Health’s bid to absorb Allina Health into a 26 billion dollar, 39-hospital nonprofit system, a real-time test of how far a state can go to slow down a hospital merger it hasn’t blessed. Attorney General Keith Ellison’s office hosted a community forum the evening of July 13, 2026 in St. Paul on the proposed deal, which would fold Allina’s Minnesota and Wisconsin operations into California-based Sutter Health as a new Upper Midwest Division while keeping the Allina name and Minneapolis headquarters; Sutter supplies the bulk of the projected 26 billion dollars in combined revenue, on 19.8 billion dollars of its own last year, and the deal carries a pledge to invest more than 2 billion dollars in Minnesota and western Wisconsin. Ellison’s office cannot unilaterally approve or block the transaction, but it is reviewing it under Minnesota’s health care transaction law, charities law, and antitrust law, and can sue to stop it if it finds a legal violation; SEIU Healthcare and the Doctors Council have raised concerns about jobs, contracts, and pensions for Allina’s workforce. A close is targeted for the end of 2026. Confidence: High. Sources: Attorney General Ellison’s announcement of the community forum, Minnesota Attorney General’s Office, Healthcare Dive’s report on the Sutter-Allina combination.
Regional One Health is shutting its 30-bed Extended Care Hospital in Memphis and laying off 103 employees, another data point in a quiet summer of post-acute contraction among safety-net systems. The system notified the state of the layoffs around July 8, 2026, tied to the closure of the Extended Care Hospital at 890 Madison Avenue effective September 1; the company cites “challenges in the current healthcare environment,” says current patients will finish their care plans on site before closure, and is offering affected staff other openings within the system. Confidence: Medium. The source is local news citing a company statement rather than a formal WARN notice or SEC-style disclosure. Source: Fox13 Memphis’s report on the Regional One Health closure.
The world’s largest blood-plasma collector is facing a fresh accountability push in Canada over two donor deaths, a reminder that the raw-material supply chain feeding blood-product manufacturers carries its own investor risk. Health Canada placed new operating conditions on 16 Grifols plasma centers in April 2026 after inspectors cited “recurring, systemic deficiencies,” including donors who should have been turned away over Creutzfeldt-Jakob disease risk factors, following the deaths of two donors at a Winnipeg clinic in October 2025 and January 2026; government reviews of the deaths found no direct link to the donation process, a conclusion one victim’s family disputes. Today, July 13, 2026, the Ontario Health Coalition and Will Trial Lawyers are holding a press conference to challenge Grifols’ undisclosed 15-year monopoly contract with Canadian Blood Services, which the groups say lets the company collect plasma at twice the public blood system’s rate and sell Canadian-sourced product internationally. Confidence: Medium on the underlying regulatory record, which is independently documented; Low on how much investor-relevant pressure the advocacy campaign itself generates, since it is not yet a government or corporate action. Sources: The Globe and Mail’s report on Health Canada’s conditions on Grifols, GlobeNewswire’s announcement of the July 13 press conference.
THE DEAL SHEET
| Target | Acquirer/Investor | Vertical | Value | Source |
|---|---|---|---|---|
| Buddy Healthcare Ltd Oy | VitalHub Corp | Digital health, care coordination | 8.6 million euros (about 9.7 million dollars) upfront, up to 4.5 million euros in earnouts | VitalHub’s acquisition announcement, GlobeNewswire via The Manila Times |
| CNS drug discovery collaboration | Insilico Medicine and China Medical System Holdings | Biopharma, AI-driven drug discovery | Up to about 1.2 billion yuan in milestone payments | Insilico Medicine’s collaboration announcement, PR Newswire |
| Canadian Dental Labs | CenterGate Capital | Dental, DSO and lab manufacturing | Undisclosed | CenterGate Capital’s partnership announcement, PR Newswire |
| Amprion Inc | Decathlon Capital Partners | Diagnostics, neurodegenerative disease | Undisclosed, non-dilutive growth financing | Amprion’s financing announcement |
No new 8-Ks or earnings releases landed in the last 24 to 48 hours from the major payers and health systems we track beyond Astrana Health’s ACO results above. UnitedHealth reports Q2 results July 16, Centene around July 28, Humana July 29, CVS August 5, and Oscar Health confirmed its results land August 6.